Isoprinosine

Inosine Pranobex, the active ingredient in Isoprinosine, is an immunostimulant presented as an oral tablet for oral use. It is employed to treat viral infections such as herpes simplex, human papillomavirus and influenza, and to support immune function in patients with immunodeficiency.

GNH USA supplies Isoprinosine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution.

Isoprinosine is used as an antiviral and immunostimulant in several viral disease categories.

Herpes simplex infections: reduces lesion duration and viral shedding. Human papillomavirus (HPV) infections: assists clearance of genital warts and related lesions. Influenza: alleviates symptoms and shortens the course of illness. Support of immune function in immunodeficient patients: enhances cellular immunity and cytokine production.

Isoprinosine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Abdominal discomfort: mild cramps or pain. - Rash: mild skin erythema. - Low‑grade fever: transient temperature rise.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hepatic enzyme elevation: possible liver function abnormalities. - Blood dyscrasias: rare cases of leukopenia or thrombocytopenia. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hemolytic anemia: destruction of red blood cells. - Autoimmune phenomena: rare onset of autoimmune disorders.

Before initiating Isoprinosine, consider the following safety measures.

Pregnancy: safety not established; avoid unless benefits outweigh risks. Breastfeeding: unknown; assess potential infant exposure. Renal impairment: use with caution; monitor renal function. Hepatic impairment: dose adjustment may be required; monitor liver enzymes. Concomitant immunosuppressants: may reduce therapeutic effect; monitor immune status. Store at ambient temperature: keep in original container, protect from moisture and light.

Isoprinosine can interact with other medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid): - Immunosuppressive agents: may blunt therapeutic effect. - Live vaccines: increased risk of infection. - Anticoagulants: potential alteration of coagulation parameters.

Moderate Interactions (Monitor Closely): - Corticosteroids: may modify immune response. - Antiretroviral drugs: possible pharmacokinetic changes. - Alcohol: may increase hepatic load and affect metabolism.